Label: information for the user
Nyzol 200 mg tablets
zonisamide
Read this label carefully before starting to take this medicine, as it contains important information for you.
This medication contains the active ingredient zonisamide, and is used as an antiepileptic.
This medication is used to treat seizures that affect a part of the brain (partial seizures), which may or may not be followed by a seizure that affects the entire brain (secondary generalization).
This medication may be used:
Do not take Nyzol:
Warnings and precautions
Zonisamide belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, severe rashes, and blood disorders, which very rarely can cause death (see section 4. Possible side effects).
There have been cases of severe rashes associated with zonisamide therapy, including cases of Stevens-Johnson syndrome. |
The use of this medicine may cause high levels of ammonia in the blood, which could change brain function, especially if you are also taking other medicines that can increase ammonia levels (e.g., valproate), if you have a genetic disorder that causes too much ammonia in the body (urea cycle disorder), or if you have liver disorders. Inform your doctor immediately if you feel drowsy or confused in an unusual way.
Consult your doctor or pharmacist before starting to take this medicine:
If any of these statements apply to you, inform your doctor before taking this medicine.
Children and adolescents
Consult your doctor about the following risks:
Prevention of heatstroke and dehydration in children This medicine can cause your child to sweat less or develop heatstroke; this can cause brain damage and death if not treated. Children are the most vulnerable group, especially on hot days. While your child is taking zonisamide:
carbonic anhydrase inhibitors (e.g., topiramate and acetazolamide) and anticholinergics (e.g., clomipramine, hydroxyzine, diphenhydramine, haloperidol, imipramine, and oxybutynin). If your child's skin is very hot with little or no sweating, the child feels confused or has muscle cramps, or their heart rate or breathing is rapid.
|
Do not administer this medicine to children under 6 years old as there is no known benefit in this age group.
Other medicines and Nyzol
Inform your doctor or pharmacist if you are using or have recently used any other medicine, including those purchased without a prescription.
Pregnancy, breastfeeding, and fertility
Women of childbearing age should use effective contraceptive measures during treatment with this medicine and for one month after stopping it.
If you intend to become pregnant, talk to your doctor before stopping contraception and before becoming pregnant about the possibility of switching to other suitable treatments. If you are or think you may be pregnant, inform your doctor immediately. Do not stop treatment without consulting your doctor.
You should only take this medicine during pregnancy if your doctor advises it. Research has shown a higher risk of birth defects in children of women taking antiepileptic medicines. The risk of birth defects or neurological developmental disorders (brain development problems) for your child after taking this medicine during pregnancy is unknown. A study showed that children whose mothers took zonisamide during pregnancy were smaller than expected for their age at birth, compared to children whose mothers were treated with lamotrigine monotherapy. Make sure you are informed in detail about the risks and benefits of using zonisamide for epilepsy during pregnancy.
Do not breastfeed while taking this medicine or for one month after stopping it.
There are no clinical data on the effects of zonisamide on human fertility. Animal studies have shown changes in fertility parameters.
Driving and operating machinery
Zonisamide may affect concentration, reaction time, and may cause drowsiness, especially at the beginning of treatment or after increasing the dose. If this medicine affects you in this way, be extra careful when driving or operating machinery.
Nyzol contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Recommended dose in adults
If taking Nyzol alone:
If taking Nyzol with other antiepileptic medications:
Use in children (6 to 11 years old) and adolescents (12 to 17 years old) weighing at least 20 kg:
Example: a child weighing 25 kg should take 25 mg once a day during the first week, and then the daily dose should be increased by 25 mg at the beginning of each week until reaching a daily dose of 150 to 200 mg.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
The tablet can be divided into equal doses.
If taking more Nyzol than you should
If you have taken more Nyzol than you should, inform the person taking care of you (family member or friend), your doctor or pharmacist, or contact the nearest hospital emergency service and bring the medication with you. You may feel drowsy and may lose consciousness. You may also feel like vomiting, have stomach pain, muscle spasms, eye movement, feel like fainting, have a slow heart rate, and decreased respiratory and renal function. Do not attempt to drive.
If you forgot to take Nyzol
If interrupting treatment with Nyzol
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Zonisamide belongs to a group of medicines (sulfonamides) that may cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely may cause death.
Get in touch with your doctor immediately if:
Get in touch with your doctor as soon as possible if:
Your doctor may decide that you should stop taking this medicine.
The side effects of zonisamide reported most frequently are all mild in nature. They occur during the first month of treatment and often decrease as treatment continues. In children aged 6 to 17 years, the side effects were consistent with those described below, except for the following: pneumonia, dehydration, decreased sweating (frequent), and abnormal liver enzymes (infrequent).
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Rare side effects(may affect up to 1 in 100 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humanowww.notificaRAM.esBy reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the box after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Do not use this medication if you observe any sign of deterioration in the tablets, blister pack, or box, or any visible sign of deterioration in the medication. Return the packaging to your pharmacist.
Medications should not be disposed of through drains or in the trash. Deposit the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. By doing so, you will help protect the environment.
Composition of Nyzol
The active ingredient is zonisamide.
Each tablet contains 200 mg of zonisamide.
The other components are: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, povidone K-25, sodium lauryl sulfate, anhydrous colloidal silica, magnesium stearate.
Appearance of the product and contents of the packaging
Nyzol is packaged in a blister pack containing 7, 14, 28, 56, 98, or 196 tablets, or in a multi-pack containing 196 tablets (2 packs of 98 tablets).
Only some sizes of packaging may be commercially available.
Marketing Authorization Holder and Responsible for Manufacturing
Marketing Authorization Holder
Avda. Barcelona, 69
08970 Sant Joan Despí – Barcelona
Spain
Responsible for Manufacturing
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
or
Neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert Str. 23
40764 Langenfeld
Germany
This medicine is authorized in the EEA member states with the following names:
Germany:Zonisamide neuraxpharm 200 mg Tablets
Spain:Nyzol 200 mg tablets
Last revision date of this leaflet:March 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.